SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+5.7%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.45B
AUM Growth
+$79.5M
(+3.4%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
9.17%
Top 10 Holdings %
Top 10 Hldgs %
45.17%
Holding
110
New
9
Increased
23
Reduced
22
Closed
11
Top Buys
| 1 |
UnitedHealth
UNH
|
$74.5M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$41.6M |
| 3 |
Biohaven
BHVN
|
$41.5M |
| 4 |
Apple
AAPL
|
$39.3M |
| 5 |
Sysco
SYY
|
$37.2M |
Top Sells
| 1 |
argenx
ARGX
|
$48M |
| 2 |
Cigna
CI
|
$43.7M |
| 3 |
McKesson
MCK
|
$32M |
| 4 |
Verizon
VZ
|
$23.5M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$22.8M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 11.21% |
| 3 | Communication Services | 6.91% |
| 4 | Consumer Discretionary | 6.1% |
| 5 | Financials | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Salesforce
CRM
$228B
| – | – |
-55,050
| Closed | -$16.6M |
|
102
Fate Therapeutics
FATE
$112M
| – | – |
-2,562,852
| Closed | -$18.8M |
|
103
Global Payments
GPN
$20.9B
| – | – |
-106,094
| Closed | -$14.2M |
|
104
Hilton Worldwide
HLT
$64.8B
| – | – |
-78,502
| Closed | -$16.7M |
|
105
Korro Bio
KRRO
$227M
| – | – |
-73,821
| Closed | -$6.64M |
|
106
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
107
Starbucks
SBUX
$99.2B
| – | – |
-172,951
| Closed | -$15.8M |
|
108
SPDR S&P 500 ETF Trust
SPY
$657B
| – | – |
0
| – | – |
|
109
Terns Pharmaceuticals
TERN
$625M
| – | – |
-1,363,675
| Closed | -$8.95M |
|
|
AKLI
110
DELISTED
Akili, Inc. Common Stock
AKLI
| – | – |
-3,841,718
| Closed | -$1.11M |
|